Uncategorized

A combination of two immunotherapy drugs is safe to give to patients with melanoma, a type of skin cancer, that has spread to the brain, and could help control the disease. Melanomas that had spread to the brain responded to, or were kept stable, by the drugs ipilimumab (Yervoy) and nivolumab (Opdivo) in around half of patients, according to an early look at unpublished results from two clinical studies. While patient numbers were small, the results could offer a new treatment option if confirmed in future studies. Dr Lynn Mara Schuchter, from the University of Pennsylvania in the US, said the findings ‘could be practice changing’. But she added that patients now need to be followed up for longer.

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-06-04-combined-immunotherapy-could-help-control-melanoma-that-has-spread-to-the-brain